|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | Jun 02 '25 | Sale | 17.50 | 30,196 | 528,413 | 168,452 | Jun 04 04:09 PM |
| NVCR | FRANCIS LEONARD | Officer | Jun 02 '25 | Proposed Sale | 19.11 | 30,196 | 577,046 | Jun 02 04:25 PM | |
| NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | Mar 03 '25 | Sale | 18.54 | 2,527 | 46,841 | 143,673 | Mar 04 04:19 PM |
| NVCR | FRANCIS LEONARD | Officer | Mar 03 '25 | Proposed Sale | 18.54 | 2,527 | 46,841 | Mar 03 05:34 PM | |
| NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | Feb 27 '25 | Sale | 20.02 | 12,266 | 245,609 | 148,970 | Mar 03 04:27 PM |
| NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | Feb 28 '25 | Sale | 18.28 | 2,770 | 50,648 | 146,200 | Mar 03 04:27 PM |
| NVCR | FRANCIS LEONARD | Officer | Feb 28 '25 | Proposed Sale | 18.28 | 2,770 | 50,647 | Feb 28 04:38 PM | |
| NVCR | FRANCIS LEONARD | Officer | Feb 27 '25 | Proposed Sale | 20.02 | 12,266 | 245,608 | Feb 27 04:28 PM | |
| NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | Nov 01 '24 | Sale | 15.94 | 598 | 9,531 | 161,236 | Nov 04 04:34 PM |
| NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | Mar 01 '24 | Sale | 16.03 | 1,679 | 26,909 | 160,938 | Mar 05 04:08 PM |
| NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | Mar 04 '24 | Sale | 16.01 | 840 | 13,448 | 160,098 | Mar 05 04:08 PM |
| NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | Feb 28 '24 | Sale | 16.14 | 2,078 | 33,545 | 162,617 | Feb 29 04:38 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Mar 03 '23 | Sale | 76.16 | 5,291 | 402,959 | 62,602 | Mar 07 04:52 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Mar 07 '23 | Sale | 75.16 | 8,318 | 625,205 | 54,284 | Mar 07 04:52 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Mar 02 '23 | Sale | 75.28 | 844 | 63,535 | 58,144 | Mar 06 04:37 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Mar 03 '23 | Sale | 77.64 | 2,059 | 159,859 | 67,893 | Mar 06 04:37 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Mar 02 '23 | Sale | 75.38 | 4,107 | 309,578 | 58,988 | Mar 03 04:13 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Mar 01 '23 | Sale | 76.36 | 1,684 | 128,594 | 63,095 | Mar 02 05:01 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Jan 05 '23 | Option Exercise | 15.39 | 35,209 | 541,697 | 53,984 | Jan 09 06:21 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Jan 05 '23 | Sale | 112.25 | 39,507 | 4,434,654 | 46,158 | Jan 09 06:21 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Oct 13 '22 | Sale | 76.01 | 6,754 | 513,372 | 43,626 | Oct 17 04:35 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Oct 06 '22 | Sale | 84.37 | 6,754 | 569,835 | 50,380 | Oct 07 04:16 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Sep 29 '22 | Sale | 77.35 | 6,754 | 522,422 | 57,134 | Sep 30 04:20 PM |
| NVCR | Leonard Frank X | President, CNS Cancers US | Sep 22 '22 | Sale | 77.00 | 6,754 | 520,058 | 63,888 | Sep 26 04:19 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Sep 15 '22 | Option Exercise | 7.15 | 5,517 | 39,447 | 82,913 | Sep 19 04:10 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Sep 15 '22 | Sale | 88.52 | 12,271 | 1,086,222 | 70,642 | Sep 19 04:10 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Sep 09 '22 | Sale | 88.00 | 1,863 | 163,944 | 84,150 | Sep 12 04:32 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Sep 06 '22 | Sale | 78.57 | 1,384 | 108,741 | 86,013 | Sep 07 04:27 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Sep 01 '22 | Sale | 77.43 | 14,212 | 1,100,476 | 87,981 | Sep 06 04:19 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Sep 02 '22 | Sale | 79.04 | 584 | 46,158 | 87,397 | Sep 06 04:19 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Aug 02 '22 | Sale | 69.66 | 414 | 28,839 | 102,193 | Aug 03 04:44 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Mar 08 '22 | Sale | 70.10 | 744 | 52,154 | 102,295 | Mar 09 04:55 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Mar 03 '22 | Sale | 74.50 | 930 | 69,283 | 103,594 | Mar 07 06:14 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Mar 04 '22 | Sale | 70.41 | 555 | 39,076 | 103,039 | Mar 07 06:14 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Sep 02 '21 | Sale | 138.23 | 540 | 74,645 | 87,153 | Sep 07 04:39 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Aug 02 '21 | Sale | 149.38 | 713 | 106,507 | 89,486 | Aug 04 05:20 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Aug 03 '21 | Sale | 149.43 | 328 | 49,013 | 89,158 | Aug 04 05:20 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Mar 08 '21 | Sale | 130.81 | 765 | 100,067 | 90,045 | Mar 10 04:07 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Mar 04 '21 | Sale | 137.55 | 567 | 77,993 | 90,810 | Mar 08 04:24 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Mar 02 '21 | Sale | 152.05 | 430 | 65,383 | 82,668 | Mar 04 05:55 PM |
| NVCR | Leonard Frank X | Chief Development Officer | Feb 27 '21 | Option Exercise | 149.10 | 1,465 | 218,432 | 83,098 | Mar 02 04:12 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite